Charm Care Future Growth
Future criteria checks 3/6
Charm Care is forecast to grow earnings and revenue by 7.2% and 8.4% per annum respectively. EPS is expected to grow by 7.2% per annum. Return on equity is forecast to be 20.6% in 3 years.
Key information
7.2%
Earnings growth rate
7.2%
EPS growth rate
Healthcare earnings growth | 7.0% |
Revenue growth rate | 8.4% |
Future return on equity | 20.6% |
Analyst coverage | Low |
Last updated | 10 Nov 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 59,300 | 5,400 | N/A | N/A | 1 |
6/30/2026 | 55,700 | 5,200 | N/A | N/A | 1 |
6/30/2025 | 49,700 | 4,750 | N/A | N/A | 1 |
9/30/2024 | 47,687 | 4,447 | N/A | N/A | N/A |
6/30/2024 | 47,829 | 4,276 | 8,806 | 10,534 | N/A |
3/31/2024 | 44,985 | 3,926 | N/A | N/A | N/A |
12/31/2023 | 41,623 | 3,585 | 2,451 | 5,333 | N/A |
9/30/2023 | 40,546 | 3,304 | N/A | N/A | N/A |
6/30/2023 | 37,887 | 3,206 | -1,617 | 496 | N/A |
3/31/2023 | 29,949 | 1,795 | N/A | N/A | N/A |
12/31/2022 | 31,411 | 3,155 | -1,975 | -231 | N/A |
9/30/2022 | 30,437 | 3,051 | N/A | N/A | N/A |
6/30/2022 | 29,071 | 2,951 | 1,336 | 3,945 | N/A |
3/31/2022 | 27,498 | 2,675 | N/A | N/A | N/A |
12/31/2021 | 24,130 | 1,292 | -2,395 | 1,361 | N/A |
9/30/2021 | 23,348 | 1,466 | N/A | N/A | N/A |
6/30/2021 | 22,984 | 1,535 | 124 | 2,558 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6062's forecast earnings growth (7.2% per year) is above the savings rate (0.3%).
Earnings vs Market: 6062's earnings (7.2% per year) are forecast to grow slower than the JP market (8% per year).
High Growth Earnings: 6062's earnings are forecast to grow, but not significantly.
Revenue vs Market: 6062's revenue (8.4% per year) is forecast to grow faster than the JP market (4.2% per year).
High Growth Revenue: 6062's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 6062's Return on Equity is forecast to be high in 3 years time (20.6%)